BC
Birchview Capital Portfolio holdings
AUM
$132M
1-Year Est. Return
53.17%
1 Year Est. Return
+53.17%
AUM
$132M
AUM Growth
+$31.8M
(+32%)
Holding
79
Top Buys
| 1 | +$6.51M | |
| 2 | +$3.06M | |
| 3 | +$1.77M | |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
+$1.19M |
| 5 |
Structure Therapeutics
GPCR
|
+$1.18M |
Top Sells
| 1 | +$1.43M | |
| 2 | +$1.17M | |
| 3 | +$964K | |
| 4 |
Axogen
AXGN
|
+$748K |
| 5 |
Xencor
XNCR
|
+$550K |
Sector Composition
| 1 | Healthcare | 76.79% |
| 2 | Technology | 17.82% |
| 3 | Energy | 4.7% |
| 4 | Materials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neuropace
NPCE
$555M
| – | – |
-16,442
|
|
||
77
10x Genomics
TXG
$2.26B
| – | – |
-22,000
|
|
||
78
Wave Life Sciences
WVE
$1.19B
| – | – |
-40,300
|
|
||
|
79
Xencor
XNCR
$1.24B
| – | – |
-70,000
|
|